The Vigabatrin REMS Program is needed by the FDA to ensure notified risk-benefit choices prior to starting therapy, and to ensure proper use of vigabatrin while clients are treated. It is not possible for your healthcare provider to understand when vision loss will occur.
One of the most typical side effect of SABRIL in children 3 to 16 years is weight gain. With serious vision loss, you might just be able to see things straight before you (in some cases called one-track mind"). You go to danger for vision loss with any kind of amount of SABRIL.
Tell your doctor if you are pregnant or plan to obtain expectant. If vision testing can not be done, your doctor may proceed suggesting SABRIL, yet will not be able to expect any kind of vision loss. If vision tests are refrained from doing regularly, your doctor might stop recommending SABRIL for you (or your child).